Left atrial appendage closure is a mechanical alternative to anticoagulation, but data regarding its use after atrial fibrillation ablation are lacking. We conducted an international randomized ...

Boston Scientific’s Watchman left atrial appendage (LAA) closure device to prevent stroke resulted in significantly less bleeding after an ablation procedure than taking blood thinners ...

Oussama Wazni, MD, Cleveland Clinic, discusses insights from the OPTION trial and their potential implication on guidelines ...

Medicare covers the surgery for the Watchman procedure, which helps those with atrial fibrillation (AFib). Learn more.

Boston Scientific Corporation announced positive three-year primary endpoint results from the OPTION global clinical trial of the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device. Key findings ...

Ablation plus LAAC resulted in better safety outcomes than ablation plus OAC in patients with AF who underwent ablation and had an increased risk for stroke.

Boston Scientific Corporation BSX recently announced favorable three-year primary endpoint data from the OPTION global clinical trial for its WATCHMAN FLX Left Atrial Appendage Closure (“LAAC ...

establishing uniform coverage for percutaneous left atrial appendage closure (LAAC) devices such as the Watchman procedure. However, individuals must meet specific criteria. Learn more about the ...